Document:

FIRST AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AND TERM LOAN AND SECURITY AGREEMENT

Exhibit 10.1

FIRST AMENDMENT TO CREDIT AGREEMENT
This First Amendment to Credit Agreement (this “Amendment”) dated and effective as of March 25, 2021 (the “First Amendment Effective Date”) by and among AXCELIS TECHNOLOGIES, INC., a Delaware corporation (the “Borrower”), the several banks and other financial institutions or entities party hereto (the “Lenders”) and SILICON VALLEY BANK (“SVB”), as the administrative agent and collateral agent (SVB, in such capacities, the “Administrative Agent”), and as the Issuing Lender and the Swingline Lender. 
​
W I T N E S S E T H:
WHEREAS, the Borrower, the Administrative Agent, the Issuing Lender and the Swingline Lender are parties to that certain Credit Agreement dated as of July 31, 2020 (as amended, modified, supplemented or restated and in effect from time to time, the “Credit Agreement”); and
WHEREAS, the Borrower has requested that the Lenders and the Administrative Agent agree to modify and amend certain terms and conditions of the Credit Agreement, subject to the terms and conditions contained herein.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1.Capitalized Terms.  All capitalized terms used herein and not otherwise defined shall have the same meaning herein as in the Credit Agreement or in the other Loan Documents, as applicable.
2.Amendments to the Credit Agreement. 
		(a)	Section 1.1 of the Credit Agreement is hereby amended by adding in the following new definitions in the appropriate alphabetical order:

““Available Tenor”: as of any date of determination and with respect to the then-current Benchmark, as applicable, any tenor for such Benchmark or payment period for interest calculated with reference to such Benchmark, as applicable, that is or may be used for determining the length of an Interest Period pursuant to this Agreement as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of Interest Period pursuant to Section 2.17(b)(iv).”
““Benchmark”: initially, the Eurodollar Rate; provided that if a Benchmark Transition Event, a Term SOFR Transition Event, or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date have occurred with respect to the Eurodollar Rate or the then-current Benchmark, then “Benchmark” means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate pursuant to Section 2.17(b)(i).”
““Benchmark Replacement”: (a) for any Available Tenor, the first alternative set forth in the order below that can be determined by the Administrative Agent for the applicable Benchmark Replacement Date:
(i) the sum of: (A) Term SOFR and (B) the related Benchmark Replacement Adjustment;

1

(ii) the sum of: (A) Daily Simple SOFR and (B) the related Benchmark Replacement Adjustment;
(iii) the sum of: (A) the alternate benchmark rate that has been selected by the Administrative Agent and the Borrower as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to (x) any selection or recommendation of a replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (y) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement for the then-current Benchmark for Dollar-denominated syndicated credit facilities at such time and (B) the related Benchmark Replacement Adjustment; 
provided that, in the case of clause (i), such Unadjusted Benchmark Replacement is displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion.
(b) With respect to any Term SOFR Transition Event, the sum of: (i) Term SOFR and (ii) the related Benchmark Replacement Adjustment. If the Benchmark Replacement as determined pursuant to clause (a) or (b) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for the purposes of this Agreement and the other Loan Documents.”
““Benchmark Replacement Adjustment”: with respect to any replacement of the then current Benchmark with an Unadjusted Benchmark Replacement for any applicable Interest Period and Available Tenor for any setting of such Unadjusted Benchmark Replacement: 
(a) for purposes of clauses (a)(i) and (ii) or (b) of the definition of “Benchmark Replacement,” the first alternative set forth in the order below that can be determined by the Administrative Agent:
(i) the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that has been selected or recommended by the Relevant Governmental Body for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for the applicable Corresponding Tenor;
(ii) the spread adjustment (which may be a positive or negative value or zero) as of the Reference Time such Benchmark Replacement is first set for such Interest Period that would apply to the fallback rate for a derivative transaction referencing the ISDA Definitions to be effective upon an index cessation event with respect to such Benchmark for the applicable Corresponding Tenor; and
(b) for purposes of clause (a)(iii) of the definition of “Benchmark Replacement,” the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower for the applicable Corresponding Tenor giving due consideration to (i) any selection or recommendation of a spread 

2

adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body on the applicable Benchmark Replacement Date or (ii) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement for Dollar denominated syndicated credit facilities; 
provided that, in the case of clause (a) above, such adjustment is displayed on a screen or other information service that publishes such Benchmark Replacement Adjustment from time to time as selected by the Administrative Agent in its reasonable discretion.”
““Benchmark Replacement Conforming Changes”: with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “ABR,” the definition of “Business Day,” the definition of “Interest Period,” timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Administrative Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).”
““Benchmark Replacement Date”: the earliest to occur of the following events with respect to the then-current Benchmark: 
(a) in the case of clause (a) or (b) of the definition of “Benchmark Transition Event,” the later of (i) the date of the public statement or publication of information referenced therein and (ii) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof);
(b) in the case of clause (c) of the definition of “Benchmark Transition Event,” the date of the public statement or publication of information referenced therein;
(c) in the case of a Term SOFR Transition Event, the date that is thirty (30) days after the Administrative Agent has provided the Term SOFR Notice to the Lenders and the Borrower pursuant to Section 2.17(b)(i)(B); or
(d) in the case of an Early Opt-in Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Administrative Agent has not received, by 5:00 p.m. (New York City time) on the 

3

fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders.
For the avoidance of doubt, (i) if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination and (ii) the Benchmark Replacement Date will be deemed to have occurred in the case of clause (a) or (b) with respect to any Benchmark upon the occurrence of the applicable event or events set forth therein with respect to all then-current Available Tenors of such Benchmark (or the published component used in the calculation thereof).”
““Benchmark Transition Event”: the occurrence of one or more of the following events with respect to the then-current Benchmark:
(a) a public statement or publication of information by or on behalf of the administrator of suchBenchmark (or the published component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof);
(b) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof), the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely; provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof); or
(c) a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are no longer representative.
For the avoidance of doubt, a Benchmark Transition Event will be deemed to have occurred with respect to any Benchmark if a public statement or publication of information set forth above has occurred with respect to each then-current Available Tenor of such Benchmark (or the published component used in the calculation thereof).”

4

““Benchmark Unavailability Period”: the period (if any) (x) beginning at the time that a Benchmark Replacement Date pursuant to clauses (a) or (b) of that definition has occurred if, at such time, no Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with this Section titled “Benchmark Replacement Setting” and (y) ending at the time that a Benchmark Replacement has replaced the then-current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.17(b).”
““Corresponding Tenor”: with respect to any Available Tenor means, as applicable, either a tenor (including overnight) or an interest payment period having approximately the same length (disregarding business day adjustment) as such Available Tenor.”
““Daily Simple SOFR”: for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by the Administrative Agent in accordance with the conventions for this rate selected or recommended by the Relevant Governmental Body for determining “Daily Simple SOFR” for syndicated business loans; provided, that if the Administrative Agent decides that any such convention is not administratively feasible for the Administrative Agent, then the Administrative Agent may establish another convention in its reasonable discretion.”
““Early Opt-in Election”: if the then-current Benchmark is the Eurodollar Rate, the occurrence of:
(a) a notification by the Administrative Agent to (or the request by the Borrower to the Administrative Agent to notify) each of the other parties hereto that at least five currently outstanding Dollar denominated syndicated credit facilities at such time contain (as a result of amendment or as originally executed) a SOFR-based rate (including SOFR, Term SOFR or any other rate based upon SOFR) as a benchmark rate (and such syndicated credit facilities are identified in such notice and are publicly available for review), and
(b) the joint election by the Administrative Agent and the Borrower to trigger a fallback from the Eurodollar Rate and the provision by the Administrative Agent of written notice of such election to the Lenders.”
““First Amendment Fee Letter”:  the fee letter agreement dated as of the First Amendment Effective Date, between the Borrower and the Administrative Agent.”
““Floor”: the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to the Eurodollar Rate.”
““ISDA Definitions”: the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time by the International Swaps and Derivatives Association, Inc. or such successor thereto.”

5

““Liquidity”:  at any date of determination, the sum of the unrestricted cash and Cash Equivalents of the Loan Parties subject to a perfected first priority Lien in favor of the Administrative Agent.”
““Reference Time”: with respect to any setting of the then-current Benchmark means (i) if such Benchmark is the Eurodollar Rate, 11:00 a.m. (London time) on the day that is two London banking days preceding the date of such setting, and (ii) if such Benchmark is not the Eurodollar Rate, the time determined by the Administrative Agent in its reasonable discretion.”
““Relevant Governmental Body”: the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.”
““SOFR”: with respect to any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day published by the SOFR Administrator on the SOFR Administrator’s Website on the immediately succeeding Business Day.”
““SOFR Administrator”: the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate).”
““SOFR Administrator’s Website”: the website of the Federal Reserve Bank of New York, currently at http://www.newyorkfed.org, or any successor source for the secured overnight financing rate identified as such by the SOFR Administrator from time to time.”
““Term SOFR”: for the applicable Corresponding Tenor as of the applicable Reference Time, the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.”
““Term SOFR Notice”: a notification by the Administrative Agent to the Lenders and the Borrower of the occurrence of a Term SOFR Transition Event.”
““Term SOFR Transition Event”: the determination by the Administrative Agent that (a) Term SOFR has been recommended for use by the Relevant Governmental Body, and is determinable for each Available Tenor, (b) the administration of Term SOFR is administratively feasible for the Administrative Agent and (c) a Benchmark Transition Event or an Early Opt-in Election, as applicable, has previously occurred resulting in a Benchmark Replacement that is not Term SOFR.”
““Unadjusted Benchmark Replacement”: the applicable Benchmark Replacement excluding the related Benchmark Replacement Adjustment.”
		(b)	Section 2.17(b) of the Credit Agreement is hereby amended and restated in its entirety as follows:

“(b) Benchmark Replacement Setting.
(i) Benchmark Replacement.

6

(A) Notwithstanding anything to the contrary herein or in any other Loan Document (and any Swap Agreement shall be deemed not to be a “Loan Document” for purposes of this Section titled “Benchmark Replacement Setting”), if a Benchmark Transition Event or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then (1) if a Benchmark Replacement is determined in accordance with clause (a)(i) or (a)(ii) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of such Benchmark setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document and (2) if a Benchmark Replacement is determined in accordance with clause (a)(iii) of the definition of “Benchmark Replacement” for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders.
(B) Notwithstanding anything to the contrary herein or in any other Loan Document and subject to the proviso below in this paragraph, if a Term SOFR Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any setting of the then-current Benchmark, then the applicable Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder or under any Loan Document in respect of such Benchmark setting and subsequent Benchmark settings, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document; provided that this clause (B) shall not be effective unless the Administrative Agent has delivered to the Lenders and the Borrower a Term SOFR Notice.  For the avoidance of doubt, the Administrative Agent shall not be required to deliver a Term SOFR Notice after a Term SOFR Transition Event and may do so in its sole discretion.
(ii) Benchmark Replacement Conforming Changes. In connection with the implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.

7

(iii) Notices; Standards for Decisions and Determinations. The Administrative Agent will promptly notify the Borrower and the Lenders of (A) any occurrence of a Benchmark Transition Event, a Term SOFR Transition Event, or an Early Opt-in Election, as applicable, and its related Benchmark Replacement Date, (B) the implementation of any Benchmark Replacement, (C) the effectiveness of any Benchmark Replacement Conforming Changes, (D) the removal or reinstatement of any tenor of a Benchmark pursuant to clause (iv) below, and (E) the commencement or conclusion of any Benchmark Unavailability Period. Any determination, decision or election that may be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders) pursuant to this Section 2.17(b) including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and without consent from any other party to this Agreement or any other Loan Document, except, in each case, as expressly required pursuant to this Section 2.17(b).
(iv) Unavailability of Tenor of Benchmark. Notwithstanding anything to the contrary herein or in any other Loan Document, at any time (including in connection with the implementation of a Benchmark Replacement), (A) if the then-current Benchmark is a term rate (including Term SOFR or the Eurodollar Rate) and either (1) any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (2) the regulatory supervisor for the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is or will be no longer representative, then the Administrative Agent may modify the definition of “Interest Period” for any Benchmark settings at or after such time to remove such unavailable or non-representative tenor and (B) if a tenor that was removed pursuant to clause (A) above either (1) is subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (2) is not, or is no longer, subject to an announcement that it is or will no longer be representative for a Benchmark (including a Benchmark Replacement), then the Administrative Agent may modify the definition of “Interest Period” for all Benchmark settings at or after such time to reinstate such previously removed tenor.
(v) Benchmark Unavailability Period. Upon the Borrower’s receipt of notice of the commencement of a Benchmark Unavailability Period, the Borrower may revoke any request for a Eurodollar Loan of, conversion to or continuation of Eurodollar Loans to be made, converted or continued during any Benchmark Unavailability Period and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to ABR Loans.”
		(c)	Section 6.2(a) of the Credit Agreement is hereby amended and restated in its entirety as follows: 

“(a)within 45 days after the end of each fiscal quarter of the Borrower, a certificate (which certification may be included in the Compliance Certificate for the fiscal quarters ending March 31, June 30 and September 30 of any fiscal year) of a Responsible Officer of the Borrower stating that all Restricted Payments made during such fiscal quarter pursuant 

8

to Section 7.6(c) satisfied the conditions set forth in Section 7.6(c) herein with respect to each such Restricted Payments and listing the amount and settlement date of each such Restricted Payment;”
		(d)	Section 6.2(b) of the Credit Agreement is hereby amended by deleting “(including for the avoidance of doubt compliance with Section 7.6(c) for the prior period).”

		(e)	Section 7.6(c) of the Credit Agreement is hereby amended and restated in its entirety as follows: 

“(c)any Group Member may make Restricted Payments so long as (i) the aggregate amount of (A) all such Restricted Payments made in any fiscal year of the Group Members plus (B) the aggregate consideration (excluding Capital Stock of the Borrower that is not Disqualified Stock, but including earn-out payments, seller debt payments or deferred purchase price payments unless repayable with Capital Stock of the Borrower that is not Disqualified Stock) paid for all Permitted Acquisitions in any fiscal year of the Group Members, shall not exceed (X) $25,000,000 if the Consolidated Senior Leverage is greater than or equal to 2.00:1.00, (Y) $50,000,000 if the Consolidated Senior Leverage is less than 2.00:1.00 and Liquidity immediately after giving effect to such Restricted Payment is less than or equal to $75,000,000 and (Z) $100,000,000 if the Consolidated Senior Leverage is less than 2.00:1.00 and Liquidity immediately after giving effect to such Restricted Payment is greater than $75,000,000, with the Consolidated Senior Leverage Ratio in each case of the foregoing items (X), (Y) and (Z), calculated on a pro forma basis after giving effect to such Permitted Acquisition or Restricted Payment, as applicable, as for the most recent determination period for which financial statements are internally available and have been delivered to the Administrative Agent and (ii) the Borrower is in pro forma compliance with the financial covenants set forth in Section 7.1 as for the most recent determination period for which financial statements are internally available and have been delivered to the Administrative Agent after giving effect to such payment;” 
		(f)	Section 7.8(n)(x) of the Credit Agreement is hereby amended and restated in its entirety as follows: 

“(x)(A) the aggregate amount of the consideration (excluding Capital Stock of the Borrower that is not Disqualified Stock, but including earn-out payments, seller debt payments or deferred purchase price payments unless repayable with Capital Stock of the Borrower that is not Disqualified Stock) paid by such Group Member in connection with (x) all Permitted Acquisitions consummated from and after the Closing Date plus (y) all Restricted Payments permitted to be made pursuant to Section 7.6(c) from and after the Closing Date, shall not exceed (1) $25,000,000 in any fiscal year of the Group Members if the Consolidated Senior Leverage Ratio is greater than or equal to 2.00:1.00, (2) $50,000,000 in any fiscal year of the Group Members if the Consolidated Senior Leverage Ratio is less than or equal to 2.00:1.00 and Liquidity immediately after giving effect such purchase or acquisition is less than or equal to $75,000,000, and (3) $100,0000,000 in any fiscal year if the Consolidated Senior Leverage is less than or equal to 2.00:1.00 and Liquidity immediately after giving effect such purchase or acquisition is greater than $75,000,000, with the Consolidated Senior Leverage Ratio in each case of the foregoing items (1), (2) and (3), subject to Section 1.4, calculated on a pro forma basis after giving effect to such purchase or acquisition or Restricted Payment, as applicable, as for the most recent determination 

9

period for which financial statements are internally available and have been delivered to the Administrative Agent;”
3.Conditions Precedent to Effectiveness.  This Amendment shall not be effective until each of the following conditions precedent have been fulfilled to the satisfaction of the Administrative Agent:
		(a)	This Amendment and the First Amendment Fee Letter shall have been duly executed and delivered by the respective parties hereto.  The Administrative Agent shall have received a fully executed copy of this Amendment and the First Amendment Fee Letter.

		(b)	All necessary consents and approvals to this Amendment shall have been obtained.

		(c)	Immediately, after giving effect to this Amendment, no Default or Event of Default shall have occurred and be continuing.

		(d)	Immediately after giving effect to this Amendment, the representations and warranties set forth in this Amendment, the Credit Agreement and the other Loan Documents, as amended by this Amendment, to which it is a party (i) that is qualified by materiality shall be true and correct, and (ii) that is not qualified by materiality, shall be true and correct in all material respects, in each case, on and as of such date as if made on and as of such date, except to the extent any such representation and warranty expressly relates to an earlier date, in which case such representation and warranty shall have been true and correct in all material respects (or all respects, as applicable) as of such earlier date.

		(e)	The Lenders and the Administrative Agent shall have received all fees required to be paid (including for the avoidance of doubt the fees specified in the First Amendment Fee Letter), and all expenses for which invoices have been presented (including the reasonable fees and expenses of legal counsel required to be paid hereunder or under any other Loan Document), on or before the First Amendment Effective Date.  

4.Representations and Warranties.  Each Loan Party hereby represents and warrants to the Administrative Agent and the Lenders as follows:
		(a)	This Amendment is, and each other Loan Document to which it is or will be a party, when executed and delivered by each Loan Party that is a party thereto, will be the legally valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with its respective terms, except as enforcement may be limited by equitable principles or by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally.

		(b)	Immediately after giving effect to this Amendment, the representations and warranties set forth in this Amendment, the Credit Agreement and the other Loan Documents, as amended by this Amendment, to which it is a party (i) that is qualified by materiality shall be true and correct, and (ii) that is not qualified by materiality, shall be true and correct in all material respects, in each case, on and as of such date as if made on and as of such date, except to the extent any such representation and warranty expressly relates to an earlier date, in which case such representation and warranty shall have been true and correct in all material respects (or all respects, as applicable) as of such earlier date.

10

5.Payment of Costs and Fees.  The Borrower shall pay to the Administrative Agent for the benefit of the Administrative Agent, all reasonable costs, out-of-pocket expenses, and fees and charges of every kind in connection with the preparation, negotiation, execution and delivery of this Amendment and any documents and instruments relating hereto (which costs include, without limitation, the reasonable fees and expenses of any attorneys retained by the Administrative Agent) to the extent provided in Section 10.5 of the Credit Agreement. All fees payable hereunder will be paid in immediately available funds and shall not be subject to reduction by way of setoff or counterclaim. 
6.Choice of Law.  This Amendment and the rights of the parties hereunder, shall be determined under, governed by, and construed in accordance with the laws of the New York.  Section 10.14 of the Credit Agreement is hereby incorporated by reference. 
7.Counterpart Execution.  This Amendment may be executed in any number of counterparts, all of which when taken together shall constitute one and the same instrument, and any of the parties hereto may execute this Amendment by signing any such counterpart.  Delivery of an executed counterpart of this Amendment by telefacsimile or other electronic method of transmission shall be equally as effective as delivery of an original executed counterpart of this Amendment.  
8.Effect on Loan Documents.
		(a)	The Credit Agreement, as amended hereby, and each of the other Loan Documents, as amended hereby, shall be and remain in full force and effect in accordance with their respective terms and hereby are ratified and confirmed in all respects.  The execution, delivery, and performance of this Amendment shall not operate as a modification or waiver of any right, power, or remedy of the Administrative Agent or any Lender under the Credit Agreement or any other Loan Document except as expressly set forth herein.  The modifications and other agreements herein are limited to the specifics hereof (including facts or occurrences on which the same are based), shall not apply with respect to any facts or occurrences other than those on which the same are based, shall not excuse any non-compliance with the Loan Documents, and shall not operate as a consent or waiver to any matter under the Loan Documents.  To the extent any terms or provisions of this Amendment conflict with those of the Credit Agreement or other Loan Documents, the terms and provisions of this Amendment shall control.

		(b)	To the extent that any terms and conditions in any of the Loan Documents shall contradict or be in conflict with any terms or conditions of the Credit Agreement, after giving effect to this Amendment, such terms and conditions are hereby deemed modified or amended accordingly to reflect the terms and conditions of the Credit Agreement as modified or amended hereby.

		(c)	This Amendment is a Loan Document.  

9.Entire Agreement.  This Amendment, and terms and provisions hereof, the Credit Agreement and the other Loan Documents constitute the entire understanding and agreement between the parties hereto with respect to the subject matter hereof and supersedes any and all prior or contemporaneous amendments or understandings with respect to the subject matter hereof, whether express or implied, oral or written.

11

10.Severability.  In case any provision in this Amendment shall be invalid, illegal or unenforceable, such provision shall be severable from the remainder of this Amendment and the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.
[Signature pages follow]

12

​

​
In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.
BORROWER:
​
	AXCELIS TECHNOLOGIES, INC. 
​
​
By: /s/ Mary G. Puma​ ​
Name: Mary G. Puma
Title: President and CEO
​
​

ny-2082196 v3 

ADMINISTRATIVE AGENT AND LENDER:
​
SILICON VALLEY BANK
​
By:/s/ Francis Ceroccia​ ​
Name: Francis Ceroccia
Title:  Director

ny-2082196 v3Exhibit 10.1

 

FORM OF SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT (this “Subscription
Agreement”) is entered into this 5th day of May, 2021, by and between Amplitude Healthcare Acquisition Corporation,
a Delaware corporation (the “Issuer”), and the undersigned (“Subscriber” or “you”).
Defined terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Business Combination Agreement
(as defined below).

 

WHEREAS, the Issuer, Jasper Therapeutics, Inc.,
a Delaware corporation (“Jasper”), and the other parties named therein will, substantially concurrently with the execution
of this Subscription Agreement, enter into that certain Business Combination Agreement, dated as of the date hereof (as amended, modified,
supplemented or waived from time to time in accordance with its terms, the “Business Combination Agreement”), pursuant
to which a wholly owned subsidiary of the Issuer will merge with and into Jasper, with Jasper surviving as a wholly owned subsidiary of
the Issuer (together with the other transactions contemplated by the Business Combination Agreement, the “Transactions”);

 

WHEREAS, in connection with the Transactions, Subscriber
desires to subscribe for and purchase from the Issuer, that number of shares of the Issuer’s Class A common stock (the “Common
Shares”) set forth on the signature page hereto (the “Subscribed Shares”) for a purchase price of $10.00
per share, and for the aggregate purchase price set forth on the signature page hereto (the “Purchase Price”), and
the Issuer desires to issue and sell to Subscriber the Subscribed Shares in consideration of the payment of the Purchase Price therefor
by or on behalf of Subscriber to the Issuer, all on the terms and subject to the conditions set forth herein; and

 

WHEREAS, concurrently with the execution of this
Subscription Agreement, and in connection with the Transactions, certain other “qualified institutional buyers” (as defined
in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”)) or “accredited investors”
(within the meaning of Rule 501(a) under the Securities Act) (each, an “Other Subscriber”) have, severally and not
jointly, entered into separate subscription agreements with the Issuer that are substantially similar to this Subscription Agreement (the
“Other Subscription Agreements”), pursuant to which such Other Subscribers have agreed to purchase Common Shares on
the Closing Date (as defined below) at the same per share purchase price as Subscriber, and the aggregate amount of securities to be sold
by the Issuer pursuant to this Subscription Agreement and the Other Subscription Agreements equals, as of the date hereof, 10,000,000
Common Shares.

 

NOW, THEREFORE, in consideration of the foregoing
and the mutual representations, warranties and covenants, and subject to the conditions, herein contained, and intending to be legally
bound hereby, the parties hereto hereby agree as follows, severally and not jointly with any Other Subscriber in the offering contemplated
by this Subscription Agreement:

 

1. Subscription.
Subject to the terms and conditions hereof, at the Closing (as defined below), Subscriber hereby agrees, upon the substantially concurrent
consummation of the Transactions, to subscribe for and purchase, and the Issuer hereby agrees to issue and sell to Subscriber, upon the
payment of the Purchase Price, the Subscribed Shares (such subscription and issuance, the “Subscription”). Notwithstanding
anything herein to the contrary, the consummation of the Subscription is contingent upon the subsequent occurrence of the closing of the
Transactions as further described herein.

 

    

     

    

 

2. Representations,
Warranties and Agreements.

 

2.1 Subscriber’s
Representations, Warranties and Agreements. To induce the Issuer to issue the Subscribed Shares, Subscriber hereby represents
and warrants to the Issuer and acknowledges and agrees with the Issuer, as of the date hereof and as of the Closing Date, as follows:

 

2.1.1 If
Subscriber is not an individual, Subscriber has been duly formed or incorporated and is validly existing in good standing under the laws
of its jurisdiction of incorporation or formation, with power and authority to enter into, deliver and perform its obligations under this
Subscription Agreement. If Subscriber is an individual, Subscriber has the authority to enter into, deliver and perform its obligations
under this Subscription Agreement.

 

2.1.2 If
Subscriber is not an individual, this Subscription Agreement has been duly authorized, validly executed and delivered by Subscriber. If
Subscriber is an individual, the signature on this Subscription Agreement is genuine, and Subscriber has legal competence and capacity
to execute the same. Assuming that this Subscription Agreement constitutes the valid and binding agreement of the Issuer, this Subscription
Agreement is the valid and binding obligation of Subscriber, and is enforceable against Subscriber in accordance with its terms, except
as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws
relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

2.1.3 The
execution, delivery and performance by Subscriber of this Subscription Agreement and the consummation of the transactions contemplated
herein do not and will not (i) if Subscriber is not an individual, result in any violation of the provisions of the organizational documents
of Subscriber or any of its subsidiaries or (ii) result in any violation of any statute or any judgment, order, rule or regulation of
any court or governmental agency or body, domestic or foreign, having jurisdiction over Subscriber that would reasonably be expected to
have a material adverse effect on the legal authority of Subscriber to enter into and timely perform its obligations under this Subscription
Agreement (a “Subscriber Material Adverse Effect”).

 

2.1.4 Subscriber
(i) is (a) either (x) a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an “accredited
investor” within the meaning of Rule 501(a) under the Securities Act or (y) an Institutional Account as defined in FINRA Rule 4512(c)
and (b) a sophisticated institutional investor, experienced in investing in transactions of the type contemplated by this Subscription
Agreement and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment
strategies involving a security or securities, including Subscriber’s participation in the purchase of the Subscribed Shares, in
each case, satisfying the applicable requirements set forth on Schedule I, (ii) is acquiring the Subscribed Shares only for his,
her or its own account and not for the account of others, or if Subscriber is subscribing for the Subscribed Shares as a fiduciary or
agent for one or more investor accounts, each owner of such account is a qualified institutional buyer, and Subscriber has full investment
discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations, warranties
and agreements herein on behalf of each owner of each such account, for investment purposes only and not with a view to any distribution
of the Subscribed Shares in any manner that would violate the securities laws of the United States or any other applicable jurisdiction
and (iii) is not acquiring the Subscribed Shares with a view to, or for offer or sale in connection with, any distribution thereof in
violation of the Securities Act (and shall provide the requested information on Schedule I following the signature page hereto).
Nothing contained herein shall be deemed a representation or warranty by Subscriber to hold the Subscribed Shares for any period of time.
Subscriber is not an entity formed for the specific purpose of acquiring the Subscribed Shares.

 

    2

     

    

 

2.1.5 Subscriber
understands that the Subscribed Shares are being offered in a transaction not involving any public offering within the meaning of the
Securities Act and that the Subscribed Shares have not been registered under the Securities Act. Except in respect of any stock lending
program, Subscriber understands that the Subscribed Shares may not be offered, resold, transferred, pledged or otherwise disposed of by
Subscriber absent an effective registration statement under the Securities Act, except (i) to the Issuer or a subsidiary thereof, (ii)
to non-U.S. persons pursuant to offers and sales that occur solely outside the United States within the meaning of Regulation S under
the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and in
each of cases (i) and (iii), in accordance with any applicable securities laws of the states and other jurisdictions of the United States,
and that the Subscribed Shares shall be subject to a legend to such effect (provided that such legends will be eligible for removal upon
compliance with the relevant resale provisions of Rule 144). Subscriber acknowledges that the Subscribed Shares will not be eligible for
resale pursuant to Rule 144 promulgated under the Securities Act until at least one (1) year from the Closing Date. Subscriber understands
and agrees that the Subscribed Shares will be subject to the foregoing restrictions and, as a result, Subscriber may not be able to readily
offer, resell, transfer, pledge or otherwise dispose of the Subscribed Shares and may be required to bear the financial risk of an investment
in the Subscribed Shares for an indefinite period of time. Subscriber understands that it has been advised to consult independent legal
counsel prior to making any offer, resale, pledge or transfer of any of the Subscribed Shares. Subscriber has determined based on its
own independent review and such professional advice as it deems appropriate that the Subscribed Shares are a suitable investment for Subscriber,
notwithstanding the substantial risks inherent in investing in or holding the Subscribed Shares.

 

2.1.6 Subscriber
understands and agrees that Subscriber is purchasing the Subscribed Shares directly from the Issuer. Subscriber further acknowledges that
there have been no representations, warranties, covenants or agreements made to Subscriber by or on behalf of the Issuer, Jasper, or any
of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the
foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and agreements
expressly set forth in this Subscription Agreement.

 

2.1.7 If
Subscriber is an employee benefit plan that is subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
Subscriber represents and warrants that its acquisition and holding of the Subscribed Shares will not constitute or result in a non-exempt
prohibited transaction under Section 406 of ERISA, Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”),
or any applicable other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the
Code (collectively, “Similar Laws”).

 

    3

     

    

 

2.1.8 In
making its decision to purchase the Subscribed Shares, Subscriber represents that it has relied upon (i) independent investigation made
by Subscriber, (ii) the SEC Documents (as defined below) and (iii) the representations, warranties and covenants of the Issuer contained
in this Subscription Agreement. Without limiting the generality of the foregoing, Subscriber has not relied on any statements or other
information provided by or on behalf of anyone (including Credit Suisse Securities (USA) LLC, Cantor Fitzgerald & Co. and William
Blair & Company, L.L.C. (collectively, in their capacity as placement agents, the “Placement Agents”)), other than
the Issuer and its representatives concerning the Issuer or the Subscribed Shares or the offer and sale of the Subscribed Shares. Subscriber
acknowledges and agrees that Subscriber has received access to and has had an adequate opportunity to review such information as Subscriber
deems necessary in order to make an investment decision with respect to the Subscribed Shares, including with respect to the Issuer, Jasper
and the Transactions, and Subscriber further acknowledges that such information is subject to change, and that any changes to such information,
including any changes based on updated information or changes in the terms of the Transactions, shall in no way affect the Subscriber’s
obligation to purchase the Subscribed Shares hereunder, except as otherwise provided herein. Subscriber represents and agrees that Subscriber
and Subscriber’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and
obtain such information as Subscriber and such Subscriber’s professional advisor(s), if any, have deemed necessary to make an investment
decision with respect to the Subscribed Shares. Except as expressly set forth herein, Subscriber represents and warrants it is relying
exclusively on its own sources of information, investment analysis and due diligence (including professional advice you deem appropriate)
with respect to the Transactions, the Subscribed Shares and the business, condition (financial and otherwise), management, operations,
properties and prospects of the Issuer and Jasper including but not limited to all business, legal, regulatory, accounting, credit and
tax matters. Subscriber further acknowledges that Subscriber has not relied upon the Placement Agents in connection with Subscriber’s
due diligence review of the offering of the Subscribed Shares and the Issuer.

 

2.1.9 Subscriber
acknowledges and agrees that (a) it has been informed that each of the Placement Agents is acting solely as placement agent in connection
with the Transactions and is not acting as an underwriter or in any other capacity in connection with the Subscriptions and is not and
shall not be construed as a fiduciary for Subscriber in connection with the Transactions, (b) the Placement Agents have not made and will
not make any representation or warranty, whether express or implied, of any kind or character and have not provided any advice or recommendation
in connection with the Transactions, in each case, to Subscriber, (c) the Placement Agents will have no responsibility to Subscriber with
respect to (i) any representations, warranties or agreements made by any person or entity under or in connection with the Transactions
or any of the documents furnished pursuant thereto or in connection therewith, or the execution, legality, validity or enforceability
(with respect to any person) thereof, or (ii) the business, condition (financial and otherwise), management, operations, properties or
prospects of, the Issuer, Jasper or the Transactions, and (d) the Placement Agents shall have no liability or obligation (including without
limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses
or disbursements incurred by Subscriber), whether in contract, tort or otherwise, to Subscriber, or to any person claiming through Subscriber,
in respect of the Transactions. Subscriber further acknowledges that Credit Suisse Securities (USA) LLC is acting as capital markets advisor
to Jasper in connection with the Transactions. Issuer and Jasper are solely responsible for paying any fees or other commission owed to
the Placement Agents in connection with the Transactions.

 

    4

     

    

 

2.1.10 Subscriber
became aware of this offering of the Subscribed Shares solely by means of direct contact between Subscriber and the Issuer or Jasper or
one of their respective representatives. Subscriber did not become aware of this offering of the Subscribed Shares, nor were the Subscribed
Shares offered to Subscriber, by any general solicitation. Subscriber acknowledges that the Issuer represents and warrants that the Subscribed
Shares were not offered by any form of general solicitation or general advertising, including methods described in section 502(c) of Regulation
D under the Securities Act.

 

2.1.11 Subscriber
understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Subscribed Shares
or made any findings or determination as to the fairness of an investment in the Subscribed Shares.

 

2.1.12 Subscriber
represents and warrants that Subscriber is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked
Persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive
Order issued by the President of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited
by any OFAC sanctions program, (ii) owned, directly or indirectly, or controlled by, or acting on behalf of, one or more persons that
are named on the OFAC List, (iii) organized, incorporated, established, located, resident or born in, or a citizen, national or the government,
including any political subdivision, agency or instrumentality thereof, of Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine
or any other country or territory embargoed or subject to substantial trade restrictions in the United States, (iv) a Designated National
as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515 or (v) a non-U.S. shell bank or providing banking services indirectly
to a non-U.S. shell bank. Subscriber agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable
law, provided that Subscriber is permitted to do so under applicable law. If Subscriber is a financial institution subject to the Bank
Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001, and its implementing regulations (collectively,
the “BSA/PATRIOT Act”), Subscriber represents that it maintains policies and procedures reasonably designed to comply
with applicable obligations under the BSA/PATRIOT Act. Subscriber also represents that, to the extent required, it maintains policies
and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs, including the OFAC List. Subscriber
further represents and warrants that, to the extent required, it maintains policies and procedures reasonably designed to ensure that
the funds held by Subscriber and used to purchase the Subscribed Shares were legally derived.

 

    5

     

    

 

2.1.13 If
Subscriber is an employee benefit plan that is subject to Title I of ERISA, a plan, an individual retirement account or other arrangement
that is subject to section 4975 of the Code or an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA),
a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA) or other plan that is
not subject to the foregoing but may be subject to provisions under any other Similar Laws or an entity whose underlying assets are considered
to include “plan assets” of any such plan, account or arrangement (each, a “Plan”), Subscriber represents
and warrants that neither the Issuer nor any of its affiliates (the “Transaction Parties”) has acted as the Plan’s
fiduciary, or has been relied on for advice, with respect to its decision to acquire and hold the Subscribed Shares, and none of the Transaction
Parties shall at any time be relied upon as the Plan’s fiduciary with respect to any decision to acquire, continue to hold or transfer
the Subscribed Shares.

 

2.1.14 Except
as expressly disclosed in a Schedule 13D or Schedule 13G (or amendments thereto) filed by such Subscriber with the United States Securities
and Exchange Commission (the “Commission”) with respect to the beneficial ownership of the Issuer’s securities,
Subscriber is not currently a member of a “group” (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or any successor provision) acting for the purpose of acquiring,
holding or disposing of equity securities of the Issuer (within the meaning of Rule 13d-5(b)(1) under the Exchange Act).

 

2.1.15 Subscriber
is not a foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state
have a substantial interest (as defined in 31 C.F.R. Part 800.244) and that will acquire a substantial interest in the Issuer as a result
of the purchase and sale of Subscribed Shares hereunder such that a declaration to the Committee on Foreign Investment in the United States
would be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208) over the
Issuer from and after the Closing as a result of the purchase and sale of the Subscribed Shares hereunder.

 

2.1.16 On
each date the Purchase Price would be required to be funded to the Issuer pursuant to Section 3.1 Subscriber will have, sufficient
immediately available funds to pay the Purchase Price pursuant to Section 3.1.

 

2.1.17 No
broker, finder or other financial consultant has acted on behalf of Subscriber in connection with this Subscription Agreement or the transactions
contemplated hereby in such a way as to create any liability on the Issuer.

 

2.2 Issuer’s
Representations, Warranties and Agreements. To induce Subscriber to purchase the Subscribed Shares, the Issuer hereby represents and
warrants to Subscriber and agrees with Subscriber, as of the date hereof and as of the Closing Date, as follows:

 

2.2.1 The
Issuer has been duly incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation, with
all requisite power and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter
into, deliver and perform its obligations under this Subscription Agreement.

 

    6

     

    

 

2.2.2 The
Subscribed Shares will be duly authorized and, when issued and delivered to Subscriber against full payment for the Subscribed Shares
and registered with the Issuer’s transfer agent, the Subscribed Shares will be validly issued, fully paid and non-assessable, will
be free and clear of any liens or other restrictions whatsoever in accordance with the terms of this Subscription Agreement and will not
have been issued in violation of or subject to any preemptive or similar rights under the Issuer’s constitutive agreements or applicable
law.

 

2.2.3 This
Subscription Agreement has been duly authorized, validly executed and delivered by the Issuer and, assuming that this Subscription Agreement
constitutes the valid and binding obligation of the Subscriber, is the valid and binding obligation of the Issuer, and is enforceable
against Issuer in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally and (ii) principles of
equity, whether considered at law or equity.

 

2.2.4 The
execution, delivery and performance of this Subscription Agreement (including compliance by the Issuer with all of the provisions hereof),
the issuance and sale of the Subscribed Shares and the consummation of the other transactions contemplated herein, including the Transactions,
will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Issuer or any of its
subsidiaries pursuant to the terms of any indenture, mortgage, charge, deed of trust, loan agreement, lease, license or other agreement
or instrument to which the Issuer or any of its subsidiaries is a party or by which the Issuer or any of its subsidiaries is bound or
to which any of the property or assets of the Issuer or any of its subsidiaries is subject, which would reasonably be expected to have
a material adverse effect on the business, properties, financial condition, stockholders’ equity or results of operations of the
Issuer or Jasper or their respective subsidiaries individually or taken as a whole and including the combined company after giving effect
to the Transactions, or materially affects the validity or enforceability of the Subscribed Shares or the legal authority or other ability
of the Issuer to enter into and timely perform its obligations under this Subscription Agreement (collectively, an “Issuer Material
Adverse Effect”), (ii) result in any violation of the provisions of the organizational documents of the Issuer or any of its
subsidiaries or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency
or body, domestic or foreign, having jurisdiction over the Issuer or any of its subsidiaries or any of its properties that would reasonably
be expected to have an Issuer Material Adverse Effect.

 

2.2.5 Neither
the Issuer, nor any person acting on its behalf has, directly or indirectly, made (and no such person or entity acting at the direction
of the Issuer will make) any offers or sales of any security of the Issuer nor solicited any offers to buy any security under circumstances
that would adversely affect reliance by the Issuer on Section 4(a)(2) of the Securities Act for the exemption from registration for the
transactions contemplated hereby or would require registration of the issuance of the Subscribed Shares under the Securities Act.

 

2.2.6 Neither
the Issuer, nor any person acting on its behalf has conducted any general solicitation or general advertising, including methods described
in section 502(c) of Regulation D under the Securities Act, in connection with the offer or sale of any of the Subscribed Shares and neither
the Issuer, nor any person acting on its behalf has offered any of the Subscribed Shares in a manner involving a public offering under,
or in a distribution in violation of, the Securities Act or any state securities laws.

 

    7

     

    

 

2.2.7 Substantially
concurrently with the execution and delivery of this Subscription Agreement, the Issuer is entering into the Other Subscription Agreements
providing for the sale of an aggregate of 10,000,000 Common Shares for an aggregate purchase price of $10.00 (including the Subscribed
Shares purchased and sold under this Subscription Agreement). There are no Other Subscription Agreements, side letter agreements or other
agreements or understandings (including written summaries of any oral understandings) with any Other Subscriber or any other investor
or potential investor with respect to the purchase of equity securities of the Issuer (other than as described in the last sentence of
this Section 2.2.7 and pursuant to the Business Combination Agreement) which include terms and conditions (economic or otherwise)
that are materially more advantageous to any such Other Subscriber, investor or potential investor (as compared to Subscriber). The Other
Subscription Agreements have not been amended or modified in any material respect following the date of this Subscription Agreement. This
Section 2.2.7 shall not apply to any purchase of any equity securities of the Issuer by the sponsor of Amplitude Healthcare Acquisition
Corporation or any of its affiliates that have been disclosed to the Subscriber. The Issuer and its affiliates shall not release any Other
Subscriber or investor (or any of its affiliates) under any Other Subscription Agreement from any of its obligations thereunder or any
other agreements (including side letters or similar agreements in respect thereof) with any Other Subscriber or investor (or any of its
affiliates) under any Other Subscription Agreement unless it offers a similar release to the Subscriber with respect to any similar obligations
it has hereunder.

 

2.2.8 As
of the date of this Subscription Agreement and the Transactions, the authorized capital stock of the Issuer consists of 100,000,000 shares
of Class A Common Stock, $0.0001 par value per share, 10,000,000 shares of Class B Common Stock, $0.0001 par value per share, and 1,000,000
shares of undesignated preferred stock, $0.0001 par value per share. As of the date of this Subscription Agreement, (i) 10,000,000 shares
of such Class A Common Stock and 2,500,000 shares of such Class B Common Stock are issued and outstanding, (ii) no shares of capital stock
of the Issuer is held in treasury by the Issuer, (iii) 4,000,000 private placement warrants (as described in the Prospectus) are issued
and outstanding and 4,000,000 shares of such authorized Class A Common Stock are issuable upon (and have been reserved solely for issuance
upon) exercise of such private placement warrants, (iv) 5,000,000 public warrants (as described in the Prospectus) are issued and outstanding
and 5,000,000 shares of such authorized Class A Common Stock are issuable upon (and have been reserved solely for issuance upon) exercise
of such public warrants and (v) there are no outstanding shares of preferred stock of the Issuer. All issued and outstanding shares of
capital stock and warrants of the Issuer have been duly authorized and validly issued, are fully paid, non-assessable and are not subject
to preemptive or similar rights. As of the date hereof, the issued and outstanding shares of Common Stock and such public warrants of
the Issuer are registered pursuant to Section 12(b) of the Exchange Act and listed for trading on the Nasdaq Capital Market under the
symbols, “AMHC” and “AMHCW”. Except as set forth above and pursuant to the Other Subscription Agreements and the
Business Combination Agreement, there are no outstanding, and between the date hereof and the Closing, the Issuer will not issue, sell
or cause to be outstanding any (a) shares, equity interests or voting securities of the Issuer, (b) securities of the Issuer convertible
into or exchangeable for shares or other equity interests or voting securities of the Issuer, (c) options, warrants or other rights (including
preemptive rights) or agreements, arrangements or commitments of any character, whether or not contingent, of the Issuer to subscribe
for, purchase or acquire from any individual, entity or other person, and no obligation of the Issuer to issue, any ordinary shares of
the Issuer, or any other equity interests or voting securities in the Issuer or any securities convertible into or exchangeable or exercisable
for such shares or other equity interests or voting securities, (d) equity equivalents or other similar rights of or with respect to the
Issuer, or (e) obligations of the Issuer to repurchase, redeem, or otherwise acquire any of the foregoing securities, shares, options,
equity equivalents, interests or rights. As of the date hereof, and between the date hereof and the Closing, the Issuer has no subsidiaries
and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated.
There are no shareholder agreements, voting trusts or other agreements or understandings to which the Issuer is a party or by which it
is bound relating to the voting of any securities of the Issuer, other than as contemplated by the Business Combination Agreement and
the Ancillary Documents (as defined in the Business Combination Agreement). There are no securities or instruments issued by or to which
the Issuer is a party containing anti-dilution or similar provisions that will be triggered by the issuance of (i) the Subscribed Shares
or (ii) the shares to be issued pursuant to any Other Subscription Agreement that have not been or will not be validly waived on or prior
to the closing of the Transactions.

 

    8

     

    

 

2.2.9 Assuming
the accuracy of Subscriber’s representations and warranties set forth in Section 2.1 of this Subscription Agreement, (i)
no registration under the Securities Act is required for the offer and sale of the Subscribed Shares by the Issuer to Subscriber and (ii)
no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal,
state or local governmental authority is required on the part of the Issuer in connection with the consummation of the transactions contemplated
by this Subscription Agreement, except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws
and filings required to consummate the Transactions as provided under the Business Combination Agreement, which filings will be made at
the Issuer’s sole expense.

 

2.2.10 There
are no pending or, to the knowledge of the Issuer, threatened, suits, claims, actions, or proceedings, which, if determined adversely,
would, individually or in the aggregate, reasonably be expected to have an Issuer Material Adverse Effect. There is no unsatisfied judgment
or any open injunction binding upon the Issuer, which would, individually or in the aggregate, reasonably be expected to have an Issuer
Material Adverse Effect.

 

2.2.11 The
Issuer is, and has been since its inception, in compliance in all material respects with all applicable laws. The Issuer has not received
any written communication from a governmental entity, exchange or self regulatory organization that alleges that the Issuer is not in
compliance in any material respect with, or is in material default or violation of, any applicable law. Subject to the last sentence of
Section 2.2.13, the Issuer is in all material respects in compliance with applicable provisions of the Sarbanes-Oxley Act of 2002,
as amended, and the rules and regulations thereunder.

 

2.2.12 The
Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection
with the execution, delivery and performance by the Issuer of this Subscription Agreement (including, without limitation, the issuance
of the Subscribed Shares), other than (i) filings with the Commission, (ii) filings required by applicable state securities laws, (iii)
filings required in accordance with Section 4, (iv) those required by the Nasdaq Capital Market, and (v) filings, the failure of
which to obtain would not be reasonably be expected to have, individually or in the aggregate, an Issuer Material Adverse Effect.

 

    9

     

    

 

2.2.13 The
Issuer has timely filed all forms, reports, schedules, exhibits, prospectuses, proxy statements and other documents required to be filed
by the Issuer with the Commission since its inception and through the date hereof. As of their respective dates, each form, report, statement,
schedule, prospectus, exhibit, proxy, registration statement and other document filed by the Issuer with the Commission prior to the date
of this Subscription Agreement (the “SEC Documents”) complied in all material respects with the applicable requirements
of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder as in effect at the
time of filing. There are no material outstanding or unresolved comments in comment letters received by the Issuer from the staff of the
Division of Corporation Finance of the SEC with respect to any of the SEC Documents. None of the SEC Documents filed under the Exchange
Act, contained, when filed or, if amended prior to the date of this Subscription Agreement, as of the date of such amendment with respect
to those disclosures that are amended, any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The Issuer
has timely filed each report, statement, schedule, prospectus, and registration statement that the Issuer was required to file with the
Commission since its inception and through the date hereof. There are no material outstanding or unresolved comments in comment letters
from the Commission staff with respect to any of the SEC Documents. Notwithstanding anything else contained herein, no representation
or warranty is made as to the accounting treatment of Issuer’s issued and outstanding warrants, or as to any deficiencies in disclosure,
accounting treatment and/or disclosure controls related to the treatment of such warrants as equity rather than liabilities by the Issuer
for purposes of its financial statements or otherwise.

 

2.2.14 No
broker, finder or other financial consultant has acted on behalf of the Issuer in connection with this Subscription Agreement or the transactions
contemplated hereby in such a way as to create any liability on Subscriber.

 

2.2.15 The
Issuer is not, and immediately after receipt of payment for the Subscribed Shares will not be, an “investment company” within
the meaning of the Investment Company Act of 1940, as amended.

 

2.2.16 The
Issuer acknowledges and agrees that, notwithstanding anything herein to the contrary, the Subscribed Shares may be pledged by the Subscriber
in connection with a bona fide margin agreement, provided such pledge shall be (i) pursuant to an available exemption from the registration
requirements of the Securities Act or (ii) pursuant to, and in accordance with, a registration statement that is effective under the Securities
Act at the time of such pledge, and the Subscriber effecting a pledge of Shares shall not be required to provide the Issuer with any notice
thereof; provided, however, that none of the Issuer, Jasper or their respective counsels shall be required to take any action (or refrain
from taking any action) in connection with any such pledge, other than providing any such lender of such margin agreement with an acknowledgment
that the Shares are not subject to any contractual prohibition on pledging or lock up, the form of such acknowledgment to be subject to
review and comment by the Issuer in all respects.

 

2.2.17 Substantially concurrently with the Closing
of this Subscription Agreement, the Issuer, Jasper, and other parties named therein, are entering into the Business Combination Agreement,
pursuant to which the Issuer will enter into the Transactions with Jasper.

 

2.2.18 There
has been no action taken by the Issuer, or, any officer, director, shareholder, manager, employee, agent or representative of the Issuer,
in each case, acting on behalf of the Issuer, in violation of any applicable Anti-Corruption Laws (as herein defined), (i) the Issuer
has not been convicted of violating any Anti-Corruption Laws or subjected to any investigation by a governmental authority for violation
of any applicable Anti-Corruption Laws, (ii) the Issuer has not conducted or initiated any internal investigation or made a voluntary,
directed, or involuntary disclosure to any governmental authority regarding any alleged act or omission arising under or relating to any
noncompliance with any Anti-Corruption Laws and (iii) the Issuer has not received any written notice or citation from a governmental authority
for any actual or potential noncompliance with any applicable Anti-Corruption Laws. As used herein, “Anti-Corruption Laws”
means any applicable laws relating to corruption and bribery, including the U.S. Foreign Corrupt Practices Act of 1977 (as amended) and
any similar law that prohibits bribery or corruption.

 

    10

     

    

 

3. Settlement
Date and Delivery.

 

3.1 Closing.
The closing of the Subscription contemplated hereby (the “Closing”) shall occur on the date of, and substantially concurrently
with (but contingent upon), the consummation of the Transactions (the date of the Closing, the “Closing Date”). Upon
written notice from (or on behalf of) the Issuer to Subscriber (the “Closing Notice”) (which notice shall specify (i)
the anticipated Closing Date and (ii) the wire instructions for delivery of the Purchase Price to the Issuer), at least five (5) Business
Days prior to the date that the Issuer reasonably expects all conditions to the closing of the Transactions to be satisfied (the “Expected
Closing Date”), upon satisfaction (or, if applicable, waiver) of the conditions set forth in this Section 3, Subscriber shall
deliver to the Issuer, (i) the Purchase Price for the Subscribed Shares, (A) no later than one (1) Business Day prior to the Expected
Closing Date by wire transfer of United States dollars in immediately available funds to the account specified by the Issuer in the Closing
Notice, such funds to be held by the Issuer in escrow until the Closing, or (B) to an account specified by the Issuer and as otherwise
mutually agreed by the Subscriber and the Issuer (“Alternative Settlement Procedures”) and (ii) any other information
that is reasonably requested in the Closing Notice in order for the Issuer to issue the Subscribed Shares, including, without limitation,
the legal name of the person in whose name the Subscribed Shares are to be issued and a duly executed Internal Revenue Service Form W-9
or W-8, as applicable. For the avoidance of doubt, mutually agreeable Alternative Settlement Procedures shall include, without limitation,
the Subscriber delivering to the Issuer on the Closing Date the Purchase Price for the Subscribed Shares by wire transfer of U.S. dollars
in immediately available funds to the account specified by the Issuer in the Closing Notice against delivery to the undersigned of the
Subscribed Shares. Notwithstanding the foregoing, for any Subscriber that informs the Issuer (1) that it is an investment company registered
under the Investment Company Act of 1940, as amended, (2) that it is advised by an investment adviser subject to regulation under the
Investment Advisers Act of 1940, as amended, or (3) that its internal compliance policies and procedures so require it, then, in lieu
of the settlement procedures above in this Section 3.1, the following shall apply: such Subscriber shall deliver at or before 8:00 a.m.
New York City time on the Closing Date (or as soon as practicable following receipt of evidence from the Issuer’s transfer agent
of the issuance to Subscriber of the Subscribed Shares on and as of the Closing Date) the Purchase Price for the Subscribed Shares being
purchased by such Subscriber by wire transfer of United States dollars in immediately available funds to the account specified by the
Issuer in the Closing Notice. On the Closing Date, the Issuer shall issue to Subscriber (or the funds and accounts designated by Subscriber
if so designated by Subscriber, or its nominee in accordance with its delivery instructions) or to a custodian designated by Subscriber,
as applicable, the Subscribed Shares, free and clear of any liens or other restrictions whatsoever (other than those arising under state
or federal securities laws), which Subscribed Shares, unless otherwise determined by the Issuer, shall be uncertificated, with record
ownership reflected only in the register of shareholders of the Issuer and shall, prior to Subscriber delivering the funds on the Closing
Date as provided in clause (i), provide evidence of such issuance from the Issuer’s transfer agent showing Subscriber as the owner
of the Subscribed Shares on and as of the Closing Date. If the Transactions are not consummated within ten (10) Business Day after the
Expected Closing Date, the Issuer shall promptly (but no later than one (1) Business Day thereafter) return the Purchase Price to Subscriber
by wire transfer of United States dollars in immediately available funds to an account specified by Subscriber, and the Subscribed Shares
shall be cancelled. Notwithstanding such return, (i) a failure to close on the Expected Closing Date shall not, by itself, be deemed to
be a failure of any of the conditions to Closing set forth in this Section 3 to be satisfied or waived on or prior to the Closing Date,
and (ii) unless and until this Subscription Agreement is terminated in accordance with Section 5 hereof, Subscriber shall remain obligated
(A) to redeliver funds to the Issuer following the Issuer’s delivery to Subscriber of a new Closing Notice and (B) to consummate
the Closing upon satisfaction of the conditions set forth in this Section 3. For purposes of this Subscription Agreement, “Business
Day” means any day that, in New York, New York, is neither a legal holiday nor a day on which banking institutions are generally
authorized or required by law or regulation to close.

 

    11

     

    

 

3.2 Conditions
to Closing of the Issuer.

 

The Issuer’s obligations to sell and issue
the Subscribed Shares at the Closing are subject to the fulfillment or (to the extent permitted by applicable law) written waiver by the
Issuer, on or prior to the Closing Date, of each of the following conditions:

 

3.2.1 Representations
and Warranties Correct. The representations and warranties made by Subscriber in Section 2.1 hereof shall be true and correct
in all material respects when made (other than the representations and warranties that are qualified as to materiality or Subscriber Material
Adverse Effect, which representations and warranties shall be true and correct in all respects), and shall be true and correct in all
material respects on and as of the Closing Date (except to the extent that any such representation and warranty is made as of an earlier
date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date) (other
than representations and warranties that are qualified as to materiality or Subscriber Material Adverse Effect, which representations
and warranties shall be true and correct in all respects) with the same force and effect as if they had been made on and as of said date.

 

3.2.2 Compliance
with Covenants. Subscriber shall have performed and complied in all material respects with the covenants and agreements required to
be performed or complied with by Subscriber under this Subscription Agreement at or prior to the Closing.

 

    12

     

    

 

3.2.3 Closing
of the Transactions. All conditions precedent to each of the Issuer’s and Jasper’s obligations to consummate, or cause
to be consummated, the Transactions set forth in the Business Combination Agreement shall have been satisfied or waived by the party entitled
to the benefit thereof under the Business Combination Agreement (other than those conditions that may only be satisfied at the consummation
of the Transactions, but subject to satisfaction or waiver by such party of such conditions as of the consummation of the Transactions),
and the Transactions will be consummated substantially concurrently with the Closing.

 

3.2.4 Legality.
There shall not be in force any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case, entered
by or with any governmental authority, statute, rule or regulation enjoining or prohibiting the consummation of the Subscription.

 

3.2.5 Amendment
of Business Combination Agreement. The terms of the Business Combination Agreement shall not have been amended in a manner that would
reasonably be expected to materially and adversely affect the economic benefits that Subscriber (in its capacity as such) would reasonably
expect to receive under this Subscription Agreement unless the Subscriber has consented in writing to such amendment.

 

3.2.6 Listing.
No suspension of the qualification of the Common Shares for offering or sale or trading in any jurisdiction, and no suspension or removal
from listing of the Common Shares on the Nasdaq Capital Market, and no initiation or threatening of any proceedings for any of such purposes
or delisting, shall have occurred, and the Subscribed Shares shall be approved for listing on the Nasdaq Capital Market, subject to official
notice of issuance.

 

3.3 Conditions
to Closing of Subscriber.

 

Subscriber’s obligation to purchase the Subscribed
Shares at the Closing is subject to the fulfillment or (to the extent permitted by applicable law) written waiver by Subscriber, on or
prior to the Closing Date, of each of the following conditions:

 

3.3.1 Representations
and Warranties Correct. The representations and warranties made by the Issuer in Section 2.2 hereof shall be true and correct
in all material respects when made (other than representations and warranties that are qualified as to materiality or Issuer Material
Adverse Effect, which representations and warranties shall be true and correct in all respects), and shall be true and correct in all
material respects on and as of the Closing Date (except to the extent that any such representation and warranty is made as of an earlier
date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date) (other
than representations and warranties that are qualified as to materiality or Issuer Material Adverse Effect, which representations and
warranties shall be true and correct in all respects) with the same force and effect as if they had been made on and as of said date,
but in each case without giving effect to consummation of the Transactions.

 

3.3.2 Compliance
with Covenants. The Issuer shall have performed and complied in all material respects with the covenants and agreements required to
be performed or complied with by the Issuer under this Subscription Agreement at or prior to the Closing.

 

    13

     

    

 

3.3.3 Closing
of the Transactions. All conditions precedent to the consummation of the Transactions set forth in the Business Combination Agreement
shall have been satisfied or waived by the party entitled to the benefit thereof under the Business Combination Agreement (other than
those conditions that may only be satisfied at the consummation of the Transactions, but subject to satisfaction or waiver by such party
of such conditions as of the consummation of the Transactions), and the Transactions will be consummated substantially concurrently with
the Closing. No amendment, modification or waiver of the Business Combination Agreement (as the same exists on the date hereof as provided
to the Subscriber) or any terms thereof shall have occurred that would reasonably be expected to materially adversely affect the economic
benefits that the Subscriber would reasonably expect to receive under this Subscription Agreement without having received the Subscriber’s
prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed).

 

3.3.4 Legality.
There shall not be in force any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case, entered
by or with any governmental authority, statute, rule or regulation enjoining or prohibiting consummation of the transactions contemplated
by this Subscription Agreement or the Transactions and no such governmental authority shall have instituted or threatened in writing a
proceeding seeking to impose any such restraint or prohibition (except in the case of a governmental authority located outside the United
States where such restraint or prohibition would not be reasonably expected to result in an Issuer Material Adverse Effect).

 

4. Registration
Statement.

 

4.1 The
Issuer agrees that, within thirty (30) calendar days after the consummation of the Transactions (the “Filing Date”),
the Issuer will file with the Commission (at the Issuer’s sole cost and expense) a registration statement (the “Registration
Statement”) registering the resale of the Subscribed Shares (the “Registrable Securities”), and the Issuer
shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing
thereof, but no later than the earlier of (i) the 60th calendar day (or 90th calendar day if the Commission notifies the Issuer that it
will “review” the Registration Statement) following the Closing Date and (ii) the 5th Business Day after the date the Issuer
is notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed”
or will not be subject to further review (such earlier date, the “Effectiveness Date”); provided, however,
that the Issuer’s obligations to include the Registrable Securities in the Registration Statement are contingent upon Subscriber
furnishing a completed and executed selling shareholders questionnaire in customary form to the Issuer that contains the information required
by Commission rules for a Registration Statement regarding Subscriber, the securities of the Issuer held by Subscriber and the intended
method of disposition of the Registrable Securities to effect the registration of the Registrable Securities, and Subscriber shall execute
such documents in connection with such registration as the Issuer may reasonably request that are customary of a selling stockholder in
similar situations, including providing that the Issuer shall be entitled to postpone and suspend the effectiveness or use of the Registration
Statement, if applicable, as permitted hereunder; provided, that Subscriber shall not in connection with the foregoing be required
to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Registrable
Securities. For purposes of clarification, any failure by the Issuer to file the Registration Statement by the Filing Date or to effect
such Registration Statement by the Effectiveness Date shall not otherwise relieve the Issuer of its obligations to file or effect the
Registration Statement as set forth above in this Section 4. For purposes of this Section 4, Registrable Securities shall
include, as of any date of determination, the Subscribed Shares and any other equity security of the Issuer issued or issuable with respect
to the Subscribed Shares by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar event
or otherwise. The Issuer will provide a draft of the Registration Statement to Subscriber for review at least two (2) Business Days in
advance of filing the Registration Statement. In no event shall Subscriber be identified as a statutory underwriter in the Registration
Statement, provided, that if the Commission requires that the Subscriber be identified as a statutory underwriter in the Registration
Statement, the Subscriber will have the option, at its sole and absolute discretion, to either (i) have the opportunity to withdraw from
the Registration Statement upon its written notice to the Issuer or (ii) be included as such in the Registration Statement. Notwithstanding
the foregoing, if the Commission prevents the Issuer from including any or all of the Subscribed Shares proposed to be registered for
resale under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Subscribed
Shares by the applicable shareholders or otherwise, (i) such Registration Statement shall register for resale such number of Subscribed
Shares which is equal to the maximum number of Subscribed Shares as is permitted by the Commission and (ii) the number of Subscribed Shares
to be registered for each selling shareholder named in the Registration Statement shall be reduced pro rata among all such selling shareholders;
and as promptly as practicable after being permitted to register additional Subscribed Shares under Rule 415 under the Securities Act,
the Issuer shall amend the Registration Statement or file a new Registration Statement to register such Subscribed Shares not included
in the initial Registration Statement and cause such amendment or Registration Statement to become effective as promptly as practicable.
For as long as the Registration Statement shall remain effective pursuant to this Subscription Agreement, the Issuer will use commercially
reasonable efforts to file all reports, and use commercially reasonable efforts to provide all customary and reasonable cooperation, necessary
to enable the undersigned to resell the Subscribed Shares pursuant to the Registration Statement or Rule 144 of the Securities Act (when
Rule 144 of the Securities Act becomes available to the Issuer), as applicable, qualify the Subscribed Shares for listing on the applicable
stock exchange on the which the Issuer’s share are then listed, and update or amend the Registration Statement as necessary to include
the Subscribed Shares as required by this Subscription Agreement.

 

    14

     

    

 

4.2 In the
case of the registration effected by the Issuer pursuant to this Subscription Agreement, the Issuer shall, upon reasonable request, inform
Subscriber as to the status of such registration. The Issuer shall, at its sole expense:

 

4.2.1 except
for such times as the Issuer is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use
its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws
which the Issuer determines to obtain, continuously effective with respect to Subscriber, and to keep the applicable Registration Statement
or any subsequent shelf registration statement free of any material misstatements or omissions, until the earlier of the following: (i)
Subscriber ceases to hold any Registrable Securities, (ii) the date all Registrable Securities held by Subscriber may be sold without
restriction under Rule 144, including without limitation, any volume and manner of sale restrictions which may be applicable to affiliates
under Rule 144 and without the requirement for the Issuer to be in compliance with the current public information required under Rule
144(c)(1) (or Rule 144(i)(2), if applicable) and (iii) three (3) years from the date of effectiveness of the Registration Statement;

 

4.2.2 advise
Subscriber, as promptly as practicable but in any event within three (3) Business Days:

 

(a) when
the Registration Statement or any post-effective amendment thereto has become effective;

 

(b) of
the issuance by the Commission of any stop order suspending the effectiveness of any Registration Statement or the initiation of any proceedings
for such purpose;

 

(c) of
the receipt by the Issuer of any notification with respect to the suspension of the qualification of the Registrable Securities included
therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(d) subject
to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any Registration
Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state a material fact required
to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under
which they were made) not misleading.

 

Notwithstanding anything to the contrary set forth herein, the Issuer
shall not, when so advising Subscriber of such events, provide Subscriber with any material, nonpublic information regarding the Issuer
other than to the extent that providing notice to Subscriber of the occurrence of the events listed in (a) through (d) above constitutes
material, nonpublic information regarding the Issuer;

 

4.2.3 use
its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement as
soon as reasonably practicable;

 

    15

     

    

 

4.2.4 upon
the occurrence of any event contemplated in Section 4.2.2(d), except for such times as the Issuer is permitted hereunder to suspend,
and has suspended, the use of a prospectus forming part of a Registration Statement, the Issuer shall use its commercially reasonable
efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration Statement or a supplement to the
related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Registrable Securities included
therein, such prospectus will not include any untrue statement of a material fact or omit to state any material fact necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading; and

 

4.2.5 use
its commercially reasonable efforts to cause all Subscribed Shares to be listed on each securities exchange or market, if any, on which
the Issuer’s common stock is then listed.

 

4.3 Notwithstanding
anything to the contrary in this Subscription Agreement, the Issuer shall be entitled to delay or postpone the effectiveness of the Registration
Statement, and from time to time to require Subscriber not to sell under the Registration Statement or to suspend the effectiveness thereof,
(i) as may be necessary in connection with the preparation and filing of a post-effective amendment to the Registration Statement following
the filing of a current, quarterly or annual report of the Issuer under the Exchange Act, or (ii) if the filing, effectiveness or continued
use of any Registration Statement would require the Issuer to make any public disclosure of material non-public information, which disclosure,
in the good faith determination of the board of directors of the Issuer, after consultation with counsel to the Issuer, (a) would be required
to be made in any Registration Statement in order for the applicable Registration Statement not to contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements contained therein not misleading, (b) would not be required to
be made at such time if a Registration Statement were not being filed at that time, and (c) the Issuer has a bona fide business purpose
for not making such information public (each such circumstance, a “Suspension Event”); provided, however, that
the Issuer may not delay or suspend the Registration Statement for a period of more than sixty (60) consecutive calendar days or more
than two (2) times or more than ninety (90) total calendar days in any three hundred and sixty (360) calendar day period. Upon receipt
of any written notice from the Issuer (which notice shall not contain any material non-public information regarding the Issuer, except
to the extent such notice itself may be deemed to constitute material non-public information) of the happening of any Suspension Event
during the period that the Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or related
prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made (in the case of the prospectus) not misleading,
Subscriber agrees that (i) it will immediately discontinue offers and sales of the Subscribed Shares under the Registration Statement
(excluding, for the avoidance of doubt, sales conducted pursuant to Rule 144) until Subscriber receives copies of a supplemental or amended
prospectus (which the Issuer agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives
notice that any post-effective amendment has become effective or unless otherwise notified by the Issuer that it may resume such offers
and sales, and (ii) it will maintain the confidentiality of any information included in such written notice delivered by the Issuer except
(A) for disclosure to Subscriber’s employees, agents and professional advisers who need to know such information and are obligated
to keep it confidential, (B) for disclosures to the extent required in order to comply with reporting obligations to its limited partners
who have agreed to keep such information confidential and (C) as required by law or subpoena. If so directed by the Issuer, Subscriber
will deliver to the Issuer or, in Subscriber’s sole discretion destroy, all copies of the prospectus covering the Subscribed Shares
in Subscriber’s possession; provided, however, that this obligation to deliver or destroy all copies of the prospectus covering
the Subscribed Shares shall not apply (A) to the extent Subscriber is required to retain a copy of such prospectus (1) in order to comply
with applicable legal, regulatory, self-regulatory or professional requirements or (2) in accordance with a bona fide pre-existing document
retention policy or (B) to copies stored electronically on archival servers as a result of automatic data back-up in the ordinary course
of business.

 

    16

     

    

 

4.4 Subscriber
may deliver written notice (including via email) in accordance with Section 6.3 (an “Opt-Out Notice”) to the
Issuer requesting that Subscriber not receive notices from the Issuer otherwise required by Section 4.3; provided, however,
that Subscriber may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice from Subscriber (unless subsequently
revoked), (i) the Issuer shall not deliver any such notices to Subscriber and Subscriber shall no longer be entitled to the rights associated
with any such notice and (ii) each time prior to Subscriber’s intended use of an effective Registration Statement, Subscriber will
notify the Issuer in writing at least two (2) Business Days in advance of such intended use, and if a notice of a Suspension Event was
previously delivered (or would have been delivered but for the provisions of this Section 4.4) and the related suspension period
remains in effect, the Issuer will so notify Subscriber, within one (1) business day of Subscriber’s notification to the Issuer,
by delivering to Subscriber a copy of such previous notice of Suspension Event, and thereafter will provide Subscriber with the related
notice of the conclusion of such Suspension Event immediately upon its availability.

 

4.5 The
parties agree that:

 

4.5.1 The
Issuer shall, notwithstanding the termination of this Subscription Agreement, indemnify and hold harmless, to the extent permitted by
law, Subscriber (to the extent a seller under the Registration Statement), the officers, directors, agents, partners, members, managers,
shareholders, affiliates, employees and investment advisers of each Subscriber, each person who controls such Subscriber (within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act), and the officers, directors, partners, members, managers, shareholders,
agents, affiliates, employees and investment advisers of each such controlling from and against any and all out-of-pocket losses, claims,
damages, liabilities, costs and expenses (including, without limitation, any reasonable attorneys’ fees and disbursements) (collectively,
“Losses”), as incurred, that arise out of or are based upon any untrue or alleged untrue statement of material fact
contained or incorporated by reference in any Registration Statement, prospectus included in any Registration Statement or preliminary
prospectus or any amendment thereof or supplement thereto or arising out of or relating to any omission or alleged omission to state a
material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or form of prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading, except insofar as the same are solely
caused by or contained in any information furnished in writing to the Issuer by or on behalf of Subscriber expressly for use therein or
Subscriber has omitted a material fact from such information; provided, however, that the indemnification contained in this
Section 4.5 shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the consent of the
Issuer (which consent shall not be unreasonably withheld, conditioned or delayed), nor shall the Issuer be liable for any Losses to the
extent they arise out of or are based upon a violation which occurs (A) in reliance upon and in conformity with written information furnished
by Subscriber, (B) in connection with any failure of such person to deliver or cause to be delivered a prospectus made available by the
Issuer in a timely manner, (C) as a result of offers or sales effected by or on behalf of any person by means of a “free writing
prospectus” (as defined in Rule 405 under the Securities Act) that was not authorized in writing by the Issuer, or (D) in connection
with any offers or sales effected by or on behalf of Subscriber in violation of Section 4.3 hereof. The Issuer shall notify Subscriber
promptly of the institution, threat or assertion of any proceeding arising from or in connection with the transactions contemplated by
this Section 4 of which the Issuer is aware.

 

    17

     

    

 

4.5.2 Subscriber
agrees, severally and not jointly with any person that is a party to the Other Subscription Agreements, to indemnify and hold harmless,
to the extent permitted by law, the Issuer, its directors, officers, employees and agents and each person who controls the Issuer (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act) against any and all Losses, as incurred, that solely
arise out of or are based upon any untrue or alleged untrue statement of material fact contained or incorporated by reference in any Registration
Statement, prospectus included in any Registration Statement or preliminary prospectus or any amendment thereof or supplement thereto
or arising out of or relating to any omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made)
not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished
in writing by such Subscriber expressly for use therein; provided, however, that the indemnification contained in this Section
4.5 shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the consent of Subscriber (which
consent shall not be unreasonably withheld, conditioned or delayed). Notwithstanding anything to the contrary herein, in no event shall
the liability of Subscriber be greater in amount than the dollar amount of the net proceeds received by Subscriber upon the sale of the
Subscribed Shares purchased pursuant to this Subscription Agreement giving rise to such indemnification obligation.

 

4.5.3 Any
person entitled to indemnification herein shall (1) give prompt written notice to the indemnifying party of any claim with respect to
which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (2) unless in such indemnified party’s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit
such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense
is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its
consent. An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees and expenses of
more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment
of legal counsel to any indemnified party a conflict of interest exists between such indemnified party and any other of such indemnified
parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party (which consent shall not
be unreasonably withheld, conditioned or delayed), consent to the entry of any judgment or enter into any settlement which cannot be settled
in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement)
or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party
of a release from all liability in respect to such claim or litigation.

 

    18

     

    

 

4.5.4 The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made
by or on behalf of the indemnified party and shall survive the transfer of the Subscribed Shares purchased pursuant to this Subscription
Agreement.

 

4.5.5 If
the indemnification provided under this Section 4.5 from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any Losses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified
party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities
and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as
well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact
or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying party
or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information
and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the Losses or other liabilities
referred to above shall be deemed to include, subject to the limitations set forth above, any legal or other fees, charges or expenses
reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 4.5 from
any person who was not guilty of such fraudulent misrepresentation. In no event shall the liability of Subscriber be greater in amount
than the dollar amount of the net proceeds received by Subscriber upon the sale of the Subscribed Shares purchased pursuant to this Subscription
Agreement giving rise to such contribution obligation.

 

4.5.6 Certificates
or book entry notations evidencing the Subscribed Shares shall not contain any legend: (i) following any sale or other transfer by the
Subscriber pursuant to the Registration Statement in accordance with the plan of distribution described therein, or (ii) following any
sale of such Subscribed Shares pursuant to Rule 144, or (iii) if such Subscribed Shares are eligible for sale under Rule 144 without volume
or manner-of-sale limitations or current information requirements and Rule 144 has been amended such that Rule 144(i) is no longer applicable
to the Subscribed Shares. The Issuer shall cause its counsel to issue a legal opinion to its transfer agent or the Subscriber promptly
if required by the transfer agent to effect the removal of the legend thereunder, or if requested by a Subscriber, respectively. The Issuer
agrees that following such time a restrictive legend is no longer required under this Section 4.6 (the “Legend Removal Date”),
the Issuer will, not later than two (2) Business Days following the receipt by Jasper of written notice from the Subscriber certifying
that a Legend Removal Date has occurred, deliver or cause to be delivered to the Subscriber a certificate or book entry notation representing
such Subscribed Shares free from any restrictive or other legends.

 

    19

     

    

 

5. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (i)
such date and time as the Business Combination Agreement is validly terminated in accordance with its terms, (ii) upon the mutual written
agreement of each of the parties hereto to terminate this Subscription Agreement, (iii) if the conditions to Closing set forth in Sections
3.2 and 3.3 of this Subscription Agreement are not satisfied or waived, or are not capable of being satisfied, on or prior
to the Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement will not be or are not consummated
at the Closing, (iv) by written notice by either party to the other party after the date that is thirty (30) days after the “Termination
Date” set forth in the Business Combination Agreement, if the Closing shall not have occurred by such date and (v) November 30,
2021; provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination,
and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from such breach.
The Issuer shall promptly notify Subscriber of the termination of the Business Combination Agreement promptly after the termination of
such agreement. Upon a valid termination of this Subscription Agreement pursuant to this Section 5, after the delivery by the Subscriber
of the Purchase Price for the Subscribed Shares, the Issuer shall promptly (but not later than one (1) Business Day thereafter) cause
the escrow agent to return the Purchase Price (to the extent such Purchase Price has been deposited in escrow).

 

6. Miscellaneous.

 

6.1 Further
Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions
as the parties reasonably may deem to be practical and necessary in order to consummate the Subscription as contemplated by this Subscription
Agreement.

 

6.1.1 Subscriber
acknowledges that the Issuer will rely on the acknowledgments, understandings, agreements, representations and warranties made by Subscriber
contained in this Subscription Agreement. The Issuer acknowledges that Subscriber will rely on the acknowledgments, understandings, agreements,
representations and warranties made by the Issuer contained in this Subscription Agreement.

 

6.1.2 Each
of the Issuer and Subscriber is entitled to rely upon this Subscription Agreement and is irrevocably authorized to produce this Subscription
Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters
covered hereby.

 

6.1.3 The
Issuer may request from Subscriber such additional information as the Issuer may reasonably deem necessary to evaluate the eligibility
of Subscriber to acquire the Subscribed Shares, and Subscriber shall provide such information as may be reasonably requested, to the extent
within Subscriber’s possession and control or otherwise readily available to Subscriber, provided that the Issuer agrees to keep
confidential any such information provided by Subscriber.

 

    20

     

    

 

6.1.4 Each
of Subscriber and the Issuer shall pay all of its own respective expenses in connection with this Subscription Agreement and the transactions
contemplated herein (it being agreed that all expenses related to the Registration Statement are for the account of the Issuer to the
extent provided in Section 4).

 

6.1.5 Each
of Subscriber and the Issuer shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably necessary
to consummate the transactions contemplated by this Subscription Agreement on the terms and conditions described therein prior to the
consummation of the Transactions.

 

6.2 Subscriber
hereby acknowledges and agrees that Subscriber will not, nor will any of Subscriber’s controlled affiliates, or any person or entity
acting on behalf of Subscriber or any of Subscriber’s controlled affiliates or pursuant to any understanding with Subscriber or
any of Subscriber’s controlled affiliates, directly or indirectly, engage in any “short sales” with respect to, any
Subscribed Shares or any securities of the Issuer or any instrument exercisable or exchangeable for or convertible into any Subscribed
Shares or any securities of the Issuer until the consummation of the Transactions (or such earlier termination of this Subscription Agreement
in accordance with its terms). For purposes hereof, “short sale” shall include, without limitation, all “short sales”
as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges, forward
sale contracts, options, puts, call, swaps, hedging activities and other similar arrangements (including on a total return basis), including
through non-US. Broker dealers or foreign regulated brokers. Notwithstanding the foregoing, (i) nothing herein shall prohibit any entities
under common management with Subscriber that have no knowledge of this Subscription Agreement or of Subscriber’s participation in
the transactions contemplated hereby (including Subscriber’s controlled affiliates and/or affiliates) from entering into any short
sales; (ii) in the case of a Subscriber that is a multi-managed investment vehicle whereby separate portfolio managers or desks manage
separate portions of such Subscriber’s assets, this Section 6.2 shall only apply with respect to the portion of assets managed
by the portfolio manager that made the investment decision to purchase the Subscribed Shares covered by this Subscription Agreement (the
“Investing Portfolio Manager”) and the portfolio managers or desks who have direct knowledge of the investment decisions made
by the Investing Portfolio Manager.

 

6.3 Notices.
Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or sent by overnight
mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and
received (i) when so delivered personally, (ii) if sent by email, upon confirmation of receipt by the intended recipient or when sent
with no undeliverable email or other rejection notice, or (iii) three (3) Business Days after the date of mailing to the address below
or to such other address or addresses as such person may hereafter designate by notice given hereunder:

 

(i) if to Subscriber, to such address or addresses set forth
on the signature page hereto;

 

    21

     

    

 

(ii) if to the Issuer, to:

 

Amplitude Healthcare Acquisition Corporation

1177 Avenue of the Americas, Floor 40

New York, NY 10036

Attention:Vishal Kapoor

Email:[*]

 

with a required copy (which copy shall not constitute notice)
to:

 

Wilmer Cutler Pickering Hale and Dorr LLP

7 World Trade Center

250 Greenwich Street

New York, NY 10007

Attention: Christopher Barnstable Brown, Esq.

Glenn Pollner, Esq.

Email:[*]

            [*]

 

6.4 Entire
Agreement. This Subscription Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof, including any commitment
letter entered into relating to the subject matter hereof.

 

6.5 Modifications
and Amendments. This Subscription Agreement may not be amended, modified, supplemented or waived except by an instrument in writing,
signed by the party against whom enforcement of such amendment, modification, supplement or waiver is sought (and in the case where the
Issuer’s consent is required, also signed by Jasper).

 

6.6 Assignment.
Neither this Subscription Agreement nor any rights, interests or obligations that may accrue to the parties hereunder (including Subscriber’s
rights to purchase the Subscribed Shares) may be transferred or assigned without the prior written consent of the Issuer; provided
that Subscriber’s rights and obligations hereunder may be assigned to any fund or account managed by the same investment manager
as Subscriber, without the prior consent of the Issuer, provided that such assignee(s) agrees in writing to be bound by the terms hereof,
and upon such assignment by a Subscriber, the assignee(s) shall become Subscriber hereunder and have the rights and obligations and be
deemed to make the representations and warranties of Subscriber provided for herein to the extent of such assignment; provided,
further that, no assignment shall relieve the assigning party of any of its obligations hereunder, including any assignment to
any fund or account managed by the same investment manager as Subscriber.

 

6.7 Benefit.
Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto
and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns. This Subscription Agreement shall not confer rights or remedies
upon any person other than the parties hereto and their respective successors and assigns, except that the Placement Agents shall be third-party
beneficiaries to the representations and warranties made by the Issuer in this Subscription Agreement. Notwithstanding anything to the
contrary herein, each party hereto agrees that Jasper is a third party beneficiary of the Subscriber’s agreement to purchase the
Subscribed Shares under this Subscription Agreement and subject to the satisfaction (or waiver) of the conditions herein, Jasper may directly
enforce (including by an action for specific performance) the obligation of Subscriber to pay the Purchase Price and acquire the Subscribed
Shares under this Subscription Agreement.

 

    22

     

    

 

6.8 Governing
Law. This Subscription Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Subscription
Agreement (whether based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement
of this Subscription Agreement, shall be governed by and construed in accordance with the laws of the State of Delaware, without giving
effect to the principles of conflicts of law thereof.

 

6.9 Consent
to Jurisdiction; Waiver of Jury Trial. Each of the parties irrevocably consents to the exclusive jurisdiction and venue of the Court
of Chancery of the State of Delaware, provided that if subject matter jurisdiction over the matter that is the subject of the legal proceeding
is vested exclusively in the U.S. federal courts, such legal proceeding shall be heard in the U.S. District Court for the District of
Delaware (together with the Court of Chancery of the State of Delaware, “Chosen Courts”), in connection with any matter
based upon or arising out of this Subscription Agreement. Each party hereby waives, and shall not assert as a defense in any legal dispute,
that (i) such person is not personally subject to the jurisdiction of the Chosen Courts for any reason, (ii) such legal proceeding may
not be brought or is not maintainable in the Chosen Courts, (iii) such person’s property is exempt or immune from execution, (iv)
such legal proceeding is brought in an inconvenient forum or (v) the venue of such legal proceeding is improper. Each party hereby consents
to service of process in any such proceeding in any manner permitted by Delaware law, further consents to service of process by nationally
recognized overnight courier service guaranteeing overnight delivery, or by registered or certified mail, return receipt requested, at
its address specified pursuant to Section 6.3 and waives and covenants not to assert or plead any objection which they might otherwise
have to such manner of service of process. Notwithstanding the foregoing in this Section 6.9, a party may commence any action,
claim, cause of action or suit in a court other than the Chosen Courts solely for the purpose of enforcing an order or judgment issued
by the Chosen Courts. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH OF THE PARTIES WAIVES ANY RIGHT TO TRIAL
BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT WHETHER NOW EXISTING OR HEREAFTER
ARISING. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY SHALL ASSERT
IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT. FURTHERMORE, NO PARTY SHALL
SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

    23

     

    

 

6.10 Severability.
If any provision of this Subscription Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of
the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full
force and effect.

 

6.11 No
Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under
this Subscription Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right, power or
remedy of such party. No single or partial exercise of any right, power or remedy under this Subscription Agreement by a party hereto,
nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from any other or
further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto shall
not constitute a waiver of the right of such party to pursue other available remedies. No notice to or demand on a party not expressly
required under this Subscription Agreement shall entitle the party receiving such notice or demand to any other or further notice or demand
in similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further
action in any circumstances without such notice or demand.

 

6.12 Remedies.

 

6.12.1 The
parties agree that irreparable damage would occur if this Subscription Agreement is not performed or the Closing is not consummated in
accordance with its specific terms or is otherwise breached and that money damages or other legal remedies would not be an adequate remedy
for any such damage. It is accordingly agreed that the parties hereto shall be entitled to equitable relief, including in the form of
an injunction or injunctions, to prevent breaches or threatened breaches of this Subscription Agreement and to enforce specifically the
terms and provisions of this Subscription Agreement in an appropriate court of competent jurisdiction as set forth in Section 6.9,
this being in addition to any other remedy to which any party is entitled at law or in equity, including money damages. The right to specific
enforcement shall include the right of the parties hereto to cause the other parties hereto to cause the transactions contemplated hereby
to be consummated on the terms and subject to the conditions and limitations set forth in this Subscription Agreement. The parties hereto
further agree (i) to waive any requirement for the security or posting of any bond in connection with any such equitable remedy, (ii)
not to assert that a remedy of specific enforcement pursuant to this Section 6.12 is unenforceable, invalid, contrary to applicable
law or inequitable for any reason and (iii) to waive any defenses in any action for specific performance, including the defense that a
remedy at law would be adequate.

 

6.12.2 The
parties acknowledge and agree that this Section 6.12 is an integral part of the transactions contemplated hereby and without that
right, the parties hereto would not have entered into this Subscription Agreement.

 

6.13 Survival
of Representations and Warranties and Covenants. All representations and warranties made by the parties hereto, and all covenants
and other agreements of the parties hereto, in this Subscription Agreement shall survive the Closing.

 

    24

     

    

 

6.14 Headings
and Captions. The headings and captions of the various subdivisions of this Subscription Agreement are for convenience of reference
only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

6.15 Counterparts.
This Subscription Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and
the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other parties, it
being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or any other form of electronic delivery, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

6.16 Construction.
The words “include,” “includes,” and “including” will be deemed to be followed by “without
limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the
singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this
Subscription Agreement,” “herein,” “hereof,” “hereby,” “hereunder,”
and words of similar import refer to this Subscription Agreement as a whole and not to any particular subdivision unless expressly so
limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have independent significance.
If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists
another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which
such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation,
warranty, or covenant. All references in this Subscription Agreement to numbers of shares, per share amounts and purchase prices shall
be appropriately adjusted to reflect any stock split, stock dividend, stock combination, recapitalization or the like occurring after
the date hereof.

 

6.17 Mutual
Drafting. This Subscription Agreement is the joint product of the parties hereto and each provision hereof has been subject to the
mutual consultation, negotiation and agreement of the parties and shall not be construed for or against any party hereto.

 

7. Cleansing
Statement; Disclosure.

 

7.1 The
Issuer shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date of this Subscription Agreement,
issue one or more press releases and/or file with the Commission a Current Report on Form 8-K (collectively, the “Disclosure
Document”) disclosing all material terms of the transactions contemplated hereby and by the Other Subscription Agreements and
the Transactions and any other material nonpublic information that the Issuer or its officers, directors, employees, agents or any other
person acting at the direction of the Issuer has provided to Subscriber in connection with the Transactions prior to the filing of the
Disclosure Document. Upon the issuance of the Disclosure Document, to the knowledge of the Issuer, Subscriber shall not be in possession
of any material, non-public information received from the Issuer or any of its officers, directors, employees, agents or any other person
acting at the direction of the Issuer, and Subscriber shall no longer be subject to any confidentiality or similar obligations under any
current agreement, whether written or oral, with the Issuer, the Placement Agents or any of their respective affiliates, relating to the
transactions contemplated by this Subscription Agreement.

 

    25

     

    

 

7.2 The
Issuer shall not (and shall cause its officers, directors, employees and agents not to) publicly disclose the name of Subscriber or any
affiliate or investment adviser of Subscriber, or include the name of Subscriber or any affiliate or investment adviser of Subscriber
without the prior written consent (including by e-mail) of Subscriber (i) in any press release or marketing materials, or (ii) in any
filing with the Commission or any regulatory agency or trading market, except (A) as required by the federal securities laws, rules or
regulations, (B) to the extent such disclosure is required by other laws, rules or regulations, at the request of the staff of the Commission
or regulatory agency or under regulations of any national securities exchange on which the Issuer’s securities are listed for trading
or (C) to the extent such announcements or other communications contain only information previously disclosed in a public statement, press
release, or other communications previously approved in accordance with this Section 7.

 

8. Trust
Account Waiver. Reference is made to the final prospectus of the Issuer filed with the Commission (File No. 333-234324) on November
21, 2019 (the “Prospectus”). Subscriber acknowledges and agrees that the Issuer has established a trust account (the
“Trust Account”) containing the proceeds of its initial public offering (the “IPO”) and from certain
private placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of the
Issuer’s public stockholders (including overallotment shares acquired by the Issuer’s underwriters), and the Issuer may disburse
monies from the Trust Account only in the express circumstances described in the Prospectus. For and in consideration of the Issuer entering
into this Subscription Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
Subscriber hereby agrees that, notwithstanding the foregoing or anything to the contrary in this Subscription Agreement, Subscriber does
not now have and shall not have at any time hereafter any right, title, interest or claim of any kind in or to any monies in the Trust
Account or distributions therefrom, or make any claims against the Trust Account (including any distributions therefrom), regardless of
whether such claim arises as to a result of, in connection with or relating in any way to, this Subscription Agreement or any proposed
or actual business relationship between the Issuer, on the one hand, and Subscriber, on the other hand, or any matter, and regardless
of whether such claim arises based on contract, tort, equity or any other theory of legal liability (and any such claims are collectively
referred to hereafter as the “Trust Account Released Claims”). Subscriber hereby irrevocably waives any Trust Account
Released Claims that it may have against the Trust Account (including distributions therefrom) now or in the future as a result of, or
arising out of, negotiations or contracts with the Issuer and will not seek recourse against the Trust Account (including any distributions
therefrom) for any reason whatsoever (including for an alleged breach of any agreement with the Issuer). Notwithstanding the foregoing,
nothing in this Section 8 shall be deemed to limit Subscriber’s right, title, interest or claim to the Trust Account by virtue of
such Subscriber’s record or beneficial ownership of securities of the Issuer, including, but not limited to, any redemption right
with respect to any such securities of the Issuer. In the event Subscriber has any claim against the Issuer under this Subscription Agreement,
Subscriber shall pursue such claim solely against the Issuer and its assets outside the Trust Account and not against the property or
any monies in the Trust Account.

 

    26

     

    

 

9. Non-Reliance
and Exculpation. Subscriber acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty
made by any person, firm or corporation, other than the representations and warranties of the Issuer expressly set forth in this Subscription
Agreement or in the SEC Documents, in making its investment or decision to invest in the Issuer. Subscriber agrees that none of (i) the
Other Subscribers pursuant to this Subscription Agreement or any other agreement related to the private placement of shares of the Issuer’s
capital stock (including the controlling persons, officers, directors, partners, agents or employees of any such Subscriber) or (ii) any
other party to the Business Combination Agreement (other than the Issuer or Jasper), including any such party’s representatives,
affiliates or any of its or their control persons, officers, directors or employees, that is not a party hereto, shall be liable to the
Subscriber pursuant to this Subscription Agreement, or to any Other Subscriber pursuant to this Subscription Agreement, any Other Subscription
Agreement or any other agreement related to the private placement of shares of the Issuer’s capital stock, the negotiation hereof
or thereof or the subject matter hereof or thereof, or the transactions contemplated hereby or thereby, for any action heretofore or hereafter
taken or omitted to be taken by any of them in connection with the purchase of the Subscribed Shares.

 

10. Rule
144. From and after such time as the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation
of the Commission that may allow Subscriber to sell securities of the Issuer to the public without registration are available to holders
of the Issuer’s shares of common stock and for so long as the Subscriber holds the Subscribed Shares, the Issuer agrees to:

 

10.1 make
and keep public information available, as those terms are understood and defined in Rule 144; and

 

10.2 file
with the Commission in a timely manner all reports and other documents required of the Issuer under the Securities Act and the Exchange
Act so long as the Issuer remains subject to such requirements and the filing of such reports and other documents is required for the
applicable provisions of Rule 144.

 

If the Subscribed Shares are eligible to be sold
without restriction under, and without the requirement for the Issuer to be in compliance with the current public information requirements
under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), then the Subscriber shall cause an opinion of nationally recognized counsel to
the Subscriber to be delivered to the Issuer and its transfer agent establishing that the applicable restrictive legend is no longer required.
Following the Issuer’s receipt of the foregoing opinion, (i) the Issuer will cause any authorizations, certificates and directions
required by the transfer agent that authorize and direct the transfer agent to issue such Subscribed Shares without any such legend to
be delivered and (ii) the Subscriber will cause customary representations and other documents, if any, reasonably requested by the Issuer,
its counsel or the transfer agent, establishing that the restrictive legends are no longer required, to be delivered. Notwithstanding
the foregoing, the Issuer will not be required to deliver any such authorization, certificate or direction if it reasonably believes that
removal of the legend could result in or facilitate transfers of securities in violation of applicable law.

 

[Signature Page Follows]

 

    27

     

    

 

IN WITNESS WHEREOF, each of the Issuer and
Subscriber has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date set
forth below.

 

	 	AMPLITUDE HEALTHCARE ACQUISITION CORPORATION
	 	By:	                               
	 		Name:
	 		Title:

 

    

     

    

 

Accepted and agreed this 5th day of May, 2021.

 

	SUBSCRIBER:	 	 	 
	 	 	 	 	 
	Signature of Subscriber:	 	 Signature of Joint Subscriber, if applicable:
	 	 	 
	By:	   	 	By:	  
	Name:	 	 	Name:	 
	Title:	 	 	Title:	 
	 	 	 		 
	Date: May 5, 2021	 	 	 
	 	 	 	 	 
	Name of Subscriber:	 	Name of Joint Subscriber, if applicable:
	 	 	 
	(Please print. Please indicate name and Capacity of person signing above)	 	(Please print. Please indicate name and Capacity of person signing above)
	 	 	 
	Name in which securities are to be registered (if different from the name of Subscriber listed directly above):	 	 	 

 

	Email Address:	 	 
	 	 	 
	If there are joint investors, please check one:	 	 
	 	 	 
	☐Joint
    Tenants with Rights of Survivorship	 	 
	 	 	 
	☐Tenants-in-Common	 	 
	 	 	 
	☐Community
    Property	 	 
	 	 	 
	Subscriber’s EIN:________________________________	 	Joint Subscriber’s EIN:______________________
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

     

     

    

 

	City, State, Zip:	 	 	City, State, Zip:	 
	 	 	 	 	 
	Attn:	 	 	Attn:	 
	 	 	 	 	 
	Telephone No.:	 	 	Telephone No.:	 
	 	 	 	 	 
	Facsimile No.:	 	 	Facsimile No.:	 

 

	Aggregate Number of Subscribed Shares subscribed for:	 	 
	 	 	 
	 	 	 
	Aggregate Purchase Price: $____________________________.	 	 

 

You must pay the Purchase Price by wire transfer of U.S. dollars in
immediately available funds, to be held in escrow until the Closing, to the account specified by the Issuer in the Closing Notice.

 

    

     

    

 

SCHEDULE I

 

ELIGIBILITY REPRESENTATIONS OF SUBSCRIBER

 

		A.	QUALIFIED INSTITUTIONAL BUYER STATUS

 

(Please check the applicable subparagraphs):

 

		1.	☐ We are a “qualified institutional buyer” (as defined
in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) (a “QIB”)).

 

		2.	☐ We are subscribing for the Subscribed Shares as a fiduciary
or agent for one or more investor accounts, and each owner of such account is a QIB.

 

*** OR ***

 

		B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS (Please check the applicable subparagraphs):

 

		1.	☐ We are an “accredited investor” (within the meaning
of Rule 501(a) under the Securities Act) or an entity in which all of the equity holders are accredited investors within the meaning of
Rule 501(a) under the Securities Act, and have marked and initialed the appropriate box on the following page indicating the provision
under which we qualify as an “accredited investor.”

 

		2.	☐ We are not a natural person.

 

*** AND ***

 

		C.	AFFILIATE STATUS

 

(Please check the applicable box) SUBSCRIBER:

 

		☐	is:

 

		☐	is not:

 

			an “affiliate” (as defined in Rule 144 under the Securities Act) of the Issuer or acting
                                                                              on behalf of an affiliate of the Issuer.

 

This page should be completed by Subscriber

and constitutes a part of the Subscription Agreement.

 

    

     

    

 

Rule 501(a) under the Securities Act, in relevant part, states that
an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer reasonably
believes comes within any of the below listed categories, at the time of the sale of the securities to that person. Subscriber has indicated,
by marking and initialing the appropriate box below, the provision(s) below which apply to Subscriber and under which Subscriber accordingly
qualifies as an “accredited investor.”

 

		☐	Any bank as defined in section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined
in section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;

 

		☐	Any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934, as amended;

 

		☐	Any insurance company as defined in section 2(a)(13) of the Securities Act;

 

		☐	Any investment company registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”)
or a business development company as defined in section 2(a)(48) of the Investment Company Act;

 

		☐	Any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small
Business Investment Act of 1958, as amended;

 

		☐	An investment adviser registered pursuant to section 203 of the Investment Advisors Act of 1940 or registered pursuant to the law
of a state;

 

		☐	An investment adviser relying on the exemption from registering with the Securities and Exchange Commission under Section 203(l) or
(m) of the Investment Advisers Act of 1940;

 

		☐	A Rural Business Investment Company as defined in section 384A of the Consolidated Farm and Rural Development Act;

 

		☐	Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

		☐	Any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
if (i) the investment decision is made by a plan fiduciary, as defined in section 3(21) of ERISA, which is either a bank, a savings and
loan association, an insurance company, or a registered investment adviser, (ii) the employee benefit plan has total assets in excess
of $5,000,000 or, (iii) such plan is a self-directed plan, with investment decisions made solely by persons that are “accredited
investors”;

 

    

     

    

 

		☐	Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940, as amended;

 

		☐	Any (i) corporation, limited liability company or partnership, (ii) Massachusetts or similar business trust, or (iii) organization
described in section 501(c)(3) of the Internal Revenue Code of 1986, as amended, not formed for the specific purpose of acquiring the
securities offered, and with total assets in excess of $5,000,000;

 

		☐	Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive
officer, or general partner of a general partner of that issuer;

 

		☐	Any natural person whose individual net worth, or joint net worth with that person’s spouse or cohabitant occupying a relationship
generally equivalent of a spouse, exceeds $1,000,000. For purposes of calculating a natural person’s net worth: (a) the person’s
primary residence shall not be included as an asset; (b) indebtedness that is secured by the person’s primary residence, up to the
estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except
that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount outstanding sixty (60) days before
such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability);
and (c) indebtedness that is secured by the person’s primary residence in excess of the estimated fair market value of the primary
residence at the time of the sale of securities shall be included as a liability;

 

		☐	Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that
person’s spouse or cohabitant occupying a relationship generally equivalent of a spouse in excess of $300,000 in each of those years
and has a reasonable expectation of reaching the same income level in the current year;

 

		☐	Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered, whose
purchase is directed by a sophisticated person as described in Section 230.506(b)(2)(ii) of Regulation D;

 

		☐	Any entity in which all of the equity owners are “accredited investors”;

 

		☐	Any natural person holding in good standing one or more professional certifications or designations or credentials from an accredited
educational institution that the SEC has designated as qualifying an individual for accredited investor status, such as a General Securities
Representative license (Series 7), a Private Securities Offerings Representative license (Series 82) and an Investment Adviser Representative
license (Series 65);

 

		☐	Any “family office” as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 which was not formed
for the purpose of investing in the Issuer, has assets under management in excess of $5,000,000 and whose prospective investment is directed
by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the
merits and risks of the prospective investment; or

 

		☐	Any “family client,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, of a family office,
whose prospective investment in the Issuer is directed by such family office, and such family office is one (i) with assets under management
in excess of $5,000,000, (ii) that was not formed for the specific purpose of investing in the Issuer, and (iii) whose prospective investment
in the Issuer is directed by a person who has such knowledge and experience in financial and business matters that such family office
is capable of evaluating the merits and risks of such prospective investment.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00327-of-00352.parquet"}]]